ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

First Test Of Cooperative Groups’ Willingness To Change Coming In New Colorectal Trials

November 14, 1986

James Shannon, 89, Led NIH In 1960’s Period of Growth

May 27, 1994

Block, Committee Agree; No New PDQ For General Public

January 11, 1985

Roanoke Awarded CHOP Contract

May 29, 1981